South & Central America Contract Research Organization (CRO) Market Size and Forecast (2021 - 2031)
Description
The South and Central America Contract Research Organization (CRO) market is projected to grow significantly, reaching approximately US$ 3,706.4 million by 2031, up from US$ 2,288.5 million in 2024, reflecting a compound annual growth rate (CAGR) of 7.1% from 2024 to 2031.
Executive Summary and Market Analysis
The South & Central America CRO market encompasses Brazil, Argentina, and other regions within South and Central America. This market is poised for substantial growth, driven by an increase in clinical trials, innovations in the clinical trial processes by pharmaceutical companies, and supportive government initiatives aimed at enhancing clinical research.
Strategic Insights
Market Segmentation Analysis
The CRO market's growth is significantly influenced by the rise of biologics and biosimilars, driven by increased competition from innovative therapies and the expiration of patents for major biologics. Biologics, including monoclonal antibodies and recombinant proteins, are expected to dominate the biopharmaceutical landscape due to their effectiveness in treating chronic and life-threatening conditions. The emergence of biosimilars, which are cost-effective alternatives to biologics, is rapidly evolving, with the World Health Organization (WHO) highlighting their role in expanding access to biologic therapies globally. Biosimilars can be up to 60% cheaper than their original counterparts, making them an attractive option for healthcare systems.
The high costs and lengthy development timelines associated with biologics are prompting companies to outsource to CROs, which can help reduce expenses and accelerate time-to-market. CROs that invest in advanced technologies and expertise in biologics and biosimilars are likely to benefit the most from this expanding market. The ongoing demand for affordable healthcare solutions continues to drive growth in the CRO sector, emphasizing their critical role in advancing biopharmaceutical development and addressing unmet medical needs.
Country Insights
The market is further analyzed by country, focusing on Brazil, Argentina, and the Rest of South and Central America, with Brazil holding the largest market share in 2024. Brazil is emerging as a key hub for clinical trials, bolstered by government initiatives aimed at enhancing the clinical research environment. Recent legislation, such as Law No. 14,874/2024, aims to improve ethical standards in clinical trials, while new regulations from the Brazilian Health Regulatory Agency (ANVISA) are designed to streamline the approval process for clinical studies. These developments are expected to increase the number of clinical trials and, consequently, the demand for CRO services.
Company Profiles
Key players in the South and Central America CRO market include Parexel International Corp, IQVIA Holdings Inc, Syneos Health Inc, Medpace Holdings Inc, Thermo Fisher Scientific (PPD Inc), ProPharma Group, Precision Medicine Group, LLC, O4 Research Ltd, Julius Clinical, Siron Clinical, Clinmark sp. z o.o., Pharmaxi LLC, Smerud Medical Research Group, and AURIGON GMBH. These companies are employing various strategies, including expansion, product innovation, and mergers and acquisitions, to enhance their market presence and offer innovative solutions to clients.
Executive Summary and Market Analysis
The South & Central America CRO market encompasses Brazil, Argentina, and other regions within South and Central America. This market is poised for substantial growth, driven by an increase in clinical trials, innovations in the clinical trial processes by pharmaceutical companies, and supportive government initiatives aimed at enhancing clinical research.
Strategic Insights
Market Segmentation Analysis
- By Service Type: The market is divided into Early Phase Development Services, Clinical Research Services, Laboratory Services, and Post-Approval Services, with Clinical Research Services holding the largest market share in 2024.
- By Product Type: Segmented into Cell and Gene Therapy, Biosimilars, Antibody Drug Conjugates, and Others, with Biosimilars leading the market in 2024.
- By Type: The market is categorized into In-house and Outsourced services, with Outsourced services dominating in 2024.
- By Application: The applications include Oncology, Neurology, Cardiology, Infectious Diseases, Metabolic Disorders, Nephrology, Respiratory, Dermatology, Ophthalmology, Hematology, and Others, where Oncology holds the largest share in 2024.
- By End User: The market is segmented into Pharmaceutical and Biotech Companies, Medical Device Companies, Academic and Research Institutes, and Others, with Pharmaceutical and Biotech Companies leading in 2024.
The CRO market's growth is significantly influenced by the rise of biologics and biosimilars, driven by increased competition from innovative therapies and the expiration of patents for major biologics. Biologics, including monoclonal antibodies and recombinant proteins, are expected to dominate the biopharmaceutical landscape due to their effectiveness in treating chronic and life-threatening conditions. The emergence of biosimilars, which are cost-effective alternatives to biologics, is rapidly evolving, with the World Health Organization (WHO) highlighting their role in expanding access to biologic therapies globally. Biosimilars can be up to 60% cheaper than their original counterparts, making them an attractive option for healthcare systems.
The high costs and lengthy development timelines associated with biologics are prompting companies to outsource to CROs, which can help reduce expenses and accelerate time-to-market. CROs that invest in advanced technologies and expertise in biologics and biosimilars are likely to benefit the most from this expanding market. The ongoing demand for affordable healthcare solutions continues to drive growth in the CRO sector, emphasizing their critical role in advancing biopharmaceutical development and addressing unmet medical needs.
Country Insights
The market is further analyzed by country, focusing on Brazil, Argentina, and the Rest of South and Central America, with Brazil holding the largest market share in 2024. Brazil is emerging as a key hub for clinical trials, bolstered by government initiatives aimed at enhancing the clinical research environment. Recent legislation, such as Law No. 14,874/2024, aims to improve ethical standards in clinical trials, while new regulations from the Brazilian Health Regulatory Agency (ANVISA) are designed to streamline the approval process for clinical studies. These developments are expected to increase the number of clinical trials and, consequently, the demand for CRO services.
Company Profiles
Key players in the South and Central America CRO market include Parexel International Corp, IQVIA Holdings Inc, Syneos Health Inc, Medpace Holdings Inc, Thermo Fisher Scientific (PPD Inc), ProPharma Group, Precision Medicine Group, LLC, O4 Research Ltd, Julius Clinical, Siron Clinical, Clinmark sp. z o.o., Pharmaxi LLC, Smerud Medical Research Group, and AURIGON GMBH. These companies are employing various strategies, including expansion, product innovation, and mergers and acquisitions, to enhance their market presence and offer innovative solutions to clients.
Table of Contents
- 1. Introduction
- 1.1 Report Guidance
- 1.2 Market Segmentation
- 2. Executive Summary
- 2.1 Key Insights
- 2.2 Market Attractiveness
- 3. Research Methodology
- 3.1 Secondary Research
- 3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macroeconomic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country-level data:
- 4. Contract Research Organization (CRO) Market Landscape
- 4.1 PEST Analysis
- 5. South and Central America Contract Research Organization (CRO) Market - Key Market Dynamics
- 5.1 Market Drivers
- 5.2 Market Restraints
- 5.3 Market Opportunities
- 5.4 Future Trends
- 5.5 Impact of Drivers and Restraints:
- 6. Contract Research Organization (CRO) Market - South and Central America Market Analysis
- 6.1 South and Central America Contract Research Organization (CRO) Market Revenue (US$ Million), 2024 - 2031
- 6.2 South and Central America Contract Research Organization (CRO) Market Forecast and Analysis
- 7. South and Central America Contract Research Organization (CRO) Market Revenue Analysis - by Service Type
- 7.1 Early Phase Development Services
- 7.1.1 Overview
- 7.1.2 Early Phase Development Services: South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
- 7.2 Clinical Research Services
- 7.2.1 Overview
- 7.2.2 Clinical Research Services: South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
- 7.3 Laboratory Services
- 7.3.1 Overview
- 7.3.2 Laboratory Services: South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
- 7.4 Post-Approval Services
- 7.4.1 Overview
- 7.4.2 Post-Approval Services: South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
- 8. South and Central America Contract Research Organization (CRO) Market Revenue Analysis - by Product Type
- 8.1 Cell and Gene Therapy
- 8.1.1 Overview
- 8.1.2 Cell and Gene Therapy: South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
- 8.2 Biosimilars
- 8.2.1 Overview
- 8.2.2 Biosimilars: South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
- 8.3 Antibody Drug Conjugates
- 8.3.1 Overview
- 8.3.2 Antibody Drug Conjugates: South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
- 8.4 Others
- 8.4.1 Overview
- 8.4.2 Others: South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
- 9. South and Central America Contract Research Organization (CRO) Market Revenue Analysis - by Type
- 9.1 In-house
- 9.1.1 Overview
- 9.1.2 In-house: South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
- 9.2 Outsource
- 9.2.1 Overview
- 9.2.2 Outsource: South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
- 10. South and Central America Contract Research Organization (CRO) Market Revenue Analysis - by Application
- 10.1 Oncology
- 10.1.1 Overview
- 10.1.2 Oncology: South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
- 10.2 Neurology
- 10.2.1 Overview
- 10.2.2 Neurology: South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
- 10.3 Cardiology
- 10.3.1 Overview
- 10.3.2 Cardiology: South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
- 10.4 Infectious Diseases
- 10.4.1 Overview
- 10.4.2 Infectious Diseases: South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
- 10.5 Metabolic Disorder
- 10.5.1 Overview
- 10.5.2 Metabolic Disorder: South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
- 10.6 Nephrology
- 10.6.1 Overview
- 10.6.2 Nephrology: South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
- 10.7 Respiratory
- 10.7.1 Overview
- 10.7.2 Respiratory: South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
- 10.8 Dermatology
- 10.8.1 Overview
- 10.8.2 Dermatology: South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
- 10.9 Ophthalmology
- 10.9.1 Overview
- 10.9.2 Ophthalmology: South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
- 10.10 Hematology
- 10.10.1 Overview
- 10.10.2 Hematology: South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
- 10.11 Others
- 10.11.1 Overview
- 10.11.2 Others: South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
- 11. South and Central America Contract Research Organization (CRO) Market Revenue Analysis - by End User
- 11.1 Pharmaceutical and Biotech Companies
- 11.1.1 Overview
- 11.1.2 Pharmaceutical and Biotech Companies: South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
- 11.2 Medical Device Companies
- 11.2.1 Overview
- 11.2.2 Medical Device Companies: South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
- 11.3 Academic and Research Institutes
- 11.3.1 Overview
- 11.3.2 Academic and Research Institutes: South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
- 11.4 Others
- 11.4.1 Overview
- 11.4.2 Others: South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
- 12. South and Central America Contract Research Organization (CRO) Market - Country Analysis
- 12.1 South and Central America
- 12.1.1 South and Central America Contract Research Organization (CRO) Market Revenue and Forecast and Analysis - by Country
- 12.1.1.1 South and Central America Contract Research Organization (CRO) Market Revenue and Forecast and Analysis - by Country
- 12.1.2.2 Brazil: South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
- 12.1.2.2.1 Brazil: South and Central America Contract Research Organization (CRO) Market Share - by Service Type
- 12.1.2.2.2 Brazil: South and Central America Contract Research Organization (CRO) Market Share - by Product Type
- 12.1.2.2.3 Brazil: South and Central America Contract Research Organization (CRO) Market Share - by Type
- 12.1.2.2.4 Brazil: South and Central America Contract Research Organization (CRO) Market Share - by Application
- 12.1.2.2.5 Brazil: South and Central America Contract Research Organization (CRO) Market Share - by End User
- 12.2.3.3 Argentina: South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
- 12.2.3.3.1 Argentina: South and Central America Contract Research Organization (CRO) Market Share - by Service Type
- 12.2.3.3.2 Argentina: South and Central America Contract Research Organization (CRO) Market Share - by Product Type
- 12.2.3.3.3 Argentina: South and Central America Contract Research Organization (CRO) Market Share - by Type
- 12.2.3.3.4 Argentina: South and Central America Contract Research Organization (CRO) Market Share - by Application
- 12.2.3.3.5 Argentina: South and Central America Contract Research Organization (CRO) Market Share - by End User
- 12.3.4.4 Rest of South and Central America: South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
- 12.3.4.4.1 Rest of South and Central America: South and Central America Contract Research Organization (CRO) Market Share - by Service Type
- 12.3.4.4.2 Rest of South and Central America: South and Central America Contract Research Organization (CRO) Market Share - by Product Type
- 12.3.4.4.3 Rest of South and Central America: South and Central America Contract Research Organization (CRO) Market Share - by Type
- 12.3.4.4.4 Rest of South and Central America: South and Central America Contract Research Organization (CRO) Market Share - by Application
- 12.3.4.4.5 Rest of South and Central America: South and Central America Contract Research Organization (CRO) Market Share - by End User
- 14 Industry Landscape
- 14.1 Overview
- 14.2 New Product Development
- 14.3 Merger and Acquisition
- 14.4 Other Strategic Developments
- 15 COMPANY PROFILES
- 15.1 Parexel International Corp
- 15.1.1 Key Facts
- 15.1.2 Business Description
- 15.1.3 Products and Services
- 15.1.4 Financial Overview
- 15.1.5 SWOT Analysis
- 15.1.6 Key Developments
- 15.2 IQVIA Holdings Inc
- 15.2.1 Key Facts
- 15.2.2 Business Description
- 15.2.3 Products and Services
- 15.2.4 Financial Overview
- 15.2.5 SWOT Analysis
- 15.2.6 Key Developments
- 15.3 Syneos Health Inc
- 15.3.1 Key Facts
- 15.3.2 Business Description
- 15.3.3 Products and Services
- 15.3.4 Financial Overview
- 15.3.5 SWOT Analysis
- 15.3.6 Key Developments
- 15.4 Medpace Holdings Inc
- 15.4.1 Key Facts
- 15.4.2 Business Description
- 15.4.3 Products and Services
- 15.4.4 Financial Overview
- 15.4.5 SWOT Analysis
- 15.4.6 Key Developments
- 15.5 Thermo Fisher Scientific (PPD Inc)
- 15.5.1 Key Facts
- 15.5.2 Business Description
- 15.5.3 Products and Services
- 15.5.4 Financial Overview
- 15.5.5 SWOT Analysis
- 15.5.6 Key Developments
- 15.6 ProPharma Group
- 15.6.1 Key Facts
- 15.6.2 Business Description
- 15.6.3 Products and Services
- 15.6.4 Financial Overview
- 15.6.5 SWOT Analysis
- 15.6.6 Key Developments
- 15.7 Precision Medicine Group, LLC.
- 15.7.1 Key Facts
- 15.7.2 Business Description
- 15.7.3 Products and Services
- 15.7.4 Financial Overview
- 15.7.5 SWOT Analysis
- 15.7.6 Key Developments
- 15.8 O4 Research Ltd
- 15.8.1 Key Facts
- 15.8.2 Business Description
- 15.8.3 Products and Services
- 15.8.4 Financial Overview
- 15.8.5 SWOT Analysis
- 15.8.6 Key Developments
- 15.9 Julius Clinical
- 15.9.1 Key Facts
- 15.9.2 Business Description
- 15.9.3 Products and Services
- 15.9.4 Financial Overview
- 15.9.5 SWOT Analysis
- 15.9.6 Key Developments
- 15.10 Siron Clinical
- 15.10.1 Key Facts
- 15.10.2 Business Description
- 15.10.3 Products and Services
- 15.10.4 Financial Overview
- 15.10.5 SWOT Analysis
- 15.10.6 Key Developments
- 15.11 Clinmark sp. z o.o.
- 15.11.1 Key Facts
- 15.11.2 Business Description
- 15.11.3 Products and Services
- 15.11.4 Financial Overview
- 15.11.5 SWOT Analysis
- 15.11.6 Key Developments
- 15.12 Pharmaxi LLC
- 15.12.1 Key Facts
- 15.12.2 Business Description
- 15.12.3 Products and Services
- 15.12.4 Financial Overview
- 15.12.5 SWOT Analysis
- 15.12.6 Key Developments
- 15.13 Smerud Medical Research Group
- 15.13.1 Key Facts
- 15.13.2 Business Description
- 15.13.3 Products and Services
- 15.13.4 Financial Overview
- 15.13.5 SWOT Analysis
- 15.13.6 Key Developments
- 15.14 AURIGON GMBH
- 15.14.1 Key Facts
- 15.14.2 Business Description
- 15.14.3 Products and Services
- 15.14.4 Financial Overview
- 15.14.5 SWOT Analysis
- 15.14.6 Key Developments
- 16. Appendix
- 16.1 About The Insight Partners
- LIST OF TABLES
- Table 1. South and Central America Contract Research Organization (CRO) Market Segmentation
- Table 3. South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
- Table 4. South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service Type
- Table 5. South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product Type
- Table 6. South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
- Table 7. South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
- Table 8. South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
- Table 9. South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Country
- Table 10. Brazil: South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service Type
- Table 11. Brazil: South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product Type
- Table 12. Brazil: South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
- Table 13. Brazil: South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
- Table 14. Brazil: South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
- Table 15. Argentina: South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service Type
- Table 16. Argentina: South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product Type
- Table 17. Argentina: South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
- Table 18. Argentina: South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
- Table 19. Argentina: South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
- Table 20. Rest of South and Central America: South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service Type
- Table 21. Rest of South and Central America: South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product Type
- Table 22. Rest of South and Central America: South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
- Table 23. Rest of South and Central America: South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
- Table 24. Rest of South and Central America: South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
- Table 25. Heat Map Analysis by Key Players
- LIST OF FIGURES
- Figure 1. South and Central America Contract Research Organization (CRO) Market Segmentation - Country
- Figure 2. PEST Analysis
- Figure 4. South and Central America Contract Research Organization (CRO) Market - Key Market Dynamics
- Figure 5. Impact Analysis of Drivers and Restraints
- Figure 6. South and Central America Contract Research Organization (CRO) Market Revenue (US$ Million), 2024 - 2031
- Figure 7. South and Central America Contract Research Organization (CRO) Market Share (%) - by Service Type, 2024 and 2031
- Figure 8. Early Phase Development Services: South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
- Figure 9. Clinical Research Services: South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
- Figure 10. Laboratory Services: South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
- Figure 11. Post-Approval Services: South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
- Figure 12. South and Central America Contract Research Organization (CRO) Market Share (%) - by Product Type, 2024 and 2031
- Figure 13. Cell and Gene Therapy: South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
- Figure 14. Biosimilars: South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
- Figure 15. Antibody Drug Conjugates: South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
- Figure 16. Others: South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
- Figure 17. South and Central America Contract Research Organization (CRO) Market Share (%) - by Type, 2024 and 2031
- Figure 18. In-house: South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
- Figure 19. Outsource: South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
- Figure 20. South and Central America Contract Research Organization (CRO) Market Share (%) - by Application, 2024 and 2031
- Figure 21. Oncology: South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
- Figure 22. Neurology: South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
- Figure 23. Cardiology: South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
- Figure 24. Infectious Diseases: South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
- Figure 25. Metabolic Disorder: South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
- Figure 26. Nephrology: South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
- Figure 27. Respiratory: South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
- Figure 28. Dermatology: South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
- Figure 29. Ophthalmology: South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
- Figure 30. Hematology: South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
- Figure 31. Others: South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
- Figure 32. South and Central America Contract Research Organization (CRO) Market Share (%) - by End User, 2024 and 2031
- Figure 33. Pharmaceutical and Biotech Companies: South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
- Figure 34. Medical Device Companies: South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
- Figure 35. Academic and Research Institutes: South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
- Figure 36. Others: South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
- Figure 37. South and Central America Contract Research Organization (CRO) Market Breakdown by Key Countries, 2024 and 2031 (%)
- Figure 38. Brazil: South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
- Figure 39. Argentina: South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
- Figure 40. Rest of South and Central America: South and Central America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
- Figure 41. Company Positioning & Concentration
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

